Anti-CD2 Antibody[LO-CD2a]

Anti-CD2 Antibody[LO-CD2a]
NEU
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
E-AN00632P.20 20 tests - -

10 - 15 Werktage*

101,00 €
E-AN00632P.100 100 tests - -

10 - 15 Werktage*

264,00 €
E-AN00632P.200 200 tests (2 x 100 tests) - -

10 - 15 Werktage*

395,00 €
 
CD2 is a 50 kD type I transmembrane glycoprotein also known as LFA-2, T11, and sheep red blood... mehr
Produktinformationen "Anti-CD2 Antibody[LO-CD2a]"
CD2 is a 50 kD type I transmembrane glycoprotein also known as LFA-2, T11, and sheep red blood cell receptor (SRBC-R). This immunoglobulin superfamily member is expressed on thymocytes, T lymphocytes, NK cells, and thymic B cell subsets. The major ligand for CD2 is CD58 (also known as LFA-3). CD2 has also been reported to bind CD48, CD59, and CD15. CD2 plays a critical role in alternative T cell activation, T cell signaling, and cell-cell adhesion. Protein function: CD2 interacts with lymphocyte function-associated antigen CD58 (LFA-3) and CD48/BCM1 to mediate adhesion between T-cells and other cell types. CD2 is implicated in the triggering of T-cells, the cytoplasmic domain is implicated in the signaling function [The UniProt Consortium]
Schlagworte: Anti-CD2, Anti-LFA-2, Anti-LFA-3 receptor, Anti-Rosette receptor, Anti-Erythrocyte receptor, Anti-T-cell surface antigen CD2, Anti-T-cell surface antigen T11/Leu-5, PE/Elab Fluor(R)594 Anti-Human CD2 Antibody[LO-CD2a]
Hersteller: Elabscience
Hersteller-Nr: E-AN00632P

Eigenschaften

Anwendung: FCM
Antikörper-Typ: Monoclonal
Klon: LO-CD2a
Konjugat: PE/EF594
Wirt: Rat
Spezies-Reaktivität: human

Handhabung & Sicherheit

Lagerung: +4°C
Versand: +4°C (International: +4°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-CD2 Antibody[LO-CD2a]"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen